Cargando…
Biosafety considerations for attenuated measles virus vectors used in virotherapy and vaccination
Attenuated measles virus (MV) is one of the most effective and safe vaccines available, making it attractive candidate vector to prevent infectious diseases. Attenuated MV have acquired the ability to use the complement regulator CD46 as a major receptor to mediate virus entry and intercellular fusi...
Autores principales: | Baldo, Aline, Galanis, Evanthia, Tangy, Frédéric, Herman, Philippe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4963060/ https://www.ncbi.nlm.nih.gov/pubmed/26631840 http://dx.doi.org/10.1080/21645515.2015.1122146 |
Ejemplares similares
-
Antitumor Virotherapy by Attenuated Measles Virus (MV)
por: Guillerme, Jean-Baptiste, et al.
Publicado: (2013) -
General Considerations on the Biosafety of Virus-derived Vectors Used in
Gene Therapy and Vaccination
por: Baldo, Aline, et al.
Publicado: (2013) -
Novel GMO-Based Vaccines against Tuberculosis: State of the Art and Biosafety Considerations
por: Leunda, Amaya, et al.
Publicado: (2014) -
Delivery and Biosafety of Oncolytic Virotherapy
por: Li, Lizhi, et al.
Publicado: (2020) -
Measles virus: Background and oncolytic virotherapy
por: Bhattacharjee, Sankhajit, et al.
Publicado: (2018)